2024 Measures

Below are the 2024 priority metrics included under AHP’s value-based contracts. Our performance to these measures not only supports excellent clinical care and population health, but also contributes to our ability to earn gain sharing and return to you a portion of the value your efforts deliver to the health care delivery system.

Adolescent Immunization (Combo #2)	DM Eye Exam	Well-Child (15 months, 6+)
Breast Cancer Screening	DM HbA1c <8%	Well-Child (15 – 30 months, 2+)
Childhood Immunization (Combo #3)	Fall Risk Management	**Depression Screening
Colorectal Cancer Screening	HTN Blood Pressure Control	**Depression Follow-up

** Measures only appear on the Provider Engagement Report

135 Corporate Woods, Suite 320
Rochester, New York 14623-1466

Phone: (585) 758-7823
Fax: (585) 424-1268

Website by:

This is not an offer to purchase or a solicitation of an offer to purchase any securities or interest in Accountable Health Partners, LLC (AHP). An offer will only be made by means of a confidential private placement memorandum and subscription agreement.

ABI Value	Interpretation	Recommendation
Greater than 1.4	Calcification/vessel hardening	Refer to vascular specialist
1.0 - 1.4	Normal	None
0.9 - 1.0	Acceptable	None
0.8 - 0.9	Some arterial disease	Treat risk factor
0.5 - 0.8	Moderate arterial disease	Refer to vascular specialist
Less than 0.5	Severe arterial disease	Refer to vascular specialist

2024 Measures

** Measures only appear on the Provider Engagement Report

GENERAL COVID-19 INFORMATION